Evidence map›Paper›PMID 22993455›Full record

ArticleTetrahedron2011

Efficient synthesis of nucleoside aryloxy phosphoramidate prodrugs utilizing benzyloxycarbonyl protection.

Jong Hyun Cho, Franck Amblard, Steven J Coats, Raymond F Schinazi

Abstract read
In one paragraph

Article in Tetrahedron, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Synthesis and Biological Evaluation of 4'-European journal of organic chemistry · 2011
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jong Hyun ChoCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Veterans Affairs Medical Center, Atlanta, GA 30033, USA.
Franck Amblard
Steven J Coats
Raymond F Schinazi

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Hannah LF Cooper · 2002 to 2026
$74.0M
Synthesis and Biotransformation of Anti-HIV ProdrugsR37AI025899 · NIAID · UNIVERSITY OF GEORGIA (UGA) · PI CHU, CHUNG K · 2001 to 2010
$4.4M
Rational Design of NRTI for Drug Resistant HIV-1R01AI071846 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MELLORS, JOHN W · 2007 to 2010
$2.9M
NUCLEOSIDES WITH DUAL ANTI-HIV AND HBV ACTIVITYR37AI041980 · NIAID · EMORY UNIVERSITY · PI SCHINAZI, RAYMOND FELIX · 2000 to 2009
$2.1M
NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI071846NIAID NIH HHS R37 AI025899NIAID NIH HHS R37 AI041980
6 · The paper itself

Abstract

An efficient method for the synthesis of nucleoside phosphoramidates prodrugs (6a-f) has been developed that employs a simple protection/deprotection sequence of the nucleoside with benzyloxycarbonyl (Cbz). The coupling reaction of Cbz-protected derivatives (5a-f) with phenyl-(ethoxy-L-alaninyl)-phosphorochloridate (7), followed by Cbz group removal by hydrogenolysis provided the phenyl phosphoramidate ProTides (6a-f) in excellent overall yields.

Identifiers

PMID22993455
PMCPMC3444294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.